The neurofibrillary tangles/tau radioligand [3H]THK-5117 available from Novandi Chemistry

Posted on aug 5, 2014

THK-5117 is a novel patented Positron Emission Tomography (PET) radiotracer that has been developed by researchers at Tohoku University (Japan). THK-5117 labels neurofibrillary tangles/tau pathology with high selectivity and through an exclusive agreement with Clino Ltd (Japan), Novandi Chemistry can now offer tritium labelled [3H]THK-5117 to the scientific community. PET imaging of neurofibrillary tangles is […]

[3H]AZD2184 now available from Novandi Chemistry

Posted on aug 4, 2014

AZD2184 is a clinically tested Positron Emission Tomography (PET) radiotracer with enhanced imaging properties. The higher signal-to-background signal of AZD2184 compared with PIB (Pittsburgh compound B) renders [3H]AZD2184 higher sensitivity and is an ideal radioligand for in vitro binding studies and visualization of amyloid plaques. Through an exclusive agreement with Navidea Biopharmaceuticals (Ohio, USA), Novandi […]

We are pleased to announce our partnership with METIS Laboratories

Posted on mar 19, 2014

Novandi Chemistry and METIS Laboratories are pleased to announce a strategic partnership. The wide range of assays offered by METIS Laboratories, and the expertise they represent in working with radiolabeled compounds makes them an ideal partner for Novandi Chemistry. METIS Laboratories was founded in 2010 and is located on Long Island, New York. METIS Laboratories is […]

The carbon-14 labelled neurotoxin [1-14C]BMAA now available from Novandi Chemistry

Posted on mar 18, 2014

The cyanobacterial neurotoxin β-methylamino-L-alanine (L-BMAA) has been implicated in the etiology of neurodegenerative disease and proposed to be biomagnified in terrestrial and aquatic food chains. BMAA is known to misincorporate into nascent proteins in place of L-serine, causing protein misfolding and aggregation, both hallmarks of tangle diseases, including Alzheimer´s, Parkinson´s, ALS, PSP and Lewy Body […]

New α7 nicotinic acetylcholine receptor radioligands available from Novandi Chemistry

Posted on okt 30, 2013

In cooperation with DanPET (Malmö, Sweden), Novandi Chemistry now can offer exclusive tritium labelled radioligands suitable for binding studies and in vitro visualization of the α7 nicotinic acetylcholine receptor (α7nAChR). The compounds [3H]NS14492 and [3H]NS10743 are patented, novel, small molecules with unique imaging properties. The compounds are α7 selective and have been shown to possess […]

New graphical profile and website launched

Posted on jun 28, 2013

We have upgraded our graphical profile and launched a new website that better corresponds to our brand. Your opinion is valuable to us and we would appreciate to get your feedback at  

Novandi Chemistry awarded by legendary swedish industrialist

Posted on jun 17, 2013

Novandi Chemistry is today awarded a monetary prize by the Sten Gustafsson Foundation at the Royal Academy of Engineering Sciences (IVA). The foundation was established in 1993 by AB Astra (now AstraZeneca) in honor of Sten Gustafsson’s invaluable contribution to Swedish industry. Alongside Novandi Chemistry is also the Södertälje based  research company MetaSafe awarded. – We are pleased and proud […]